Old drugs give new hope in cancer

+News
In print

Old drugs give new hope in cancer

NZD

New Zealand Doctor Rata Aotearoa

David Young, Swee Tan, Ruth Watson-Black
Cancer-drug study doctor David Young with Gillies McIndoe Research Institute director Swee Tan and study coordinator Ruth Watson-Black – phase II trial is ready to launch once funding is finalised [image: Supplied]

Virginia McMillan follows up on the cancer-drug trial she first reported in 2017, when patients with glioblastoma were being recruited to test a regimen of repurposed drugs

The 17 patients in an internation­ally novel clinical trial run from Hutt Valley did not live to see the promising results of the drug regimen they we
References

O’Rawe M, Wickremesekera A, Pandey R et al. Treatment of glioblastoma with re-purposed renin-angiotensin system modulators: Results of a phase I clinical trial. J Clin Neurosci 2022;95:48–54.

DOI:https://doi.org/10.1016/j.jocn.2021.11.023